Thomas Jonassen

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 1 buy · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€6,627

▼ Sales (1 ops.)

€558k

Latest filing published 07 Sept 2026 for SynAct Pharma AB, €558k. Read the official filing

Filing timeline

BuySale

Thomas Jonassen

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

SynAct Pharma AB 1 purchase · last 31 Dec 2025

Since each purchase

SynAct Pharma AB
Filed 31 Dec 2025 · 291 days ago · €6,627
-24.7%
Entry SEK 22.45 · Close 09 Oct 2026 SEK 16.90

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Thomas Jonassen: trading record in brief

Thomas Jonassen appears in our data through filings on SynAct Pharma AB shares, published by Finansinspektionen. The record holds 5 filings, for trades running from 6 January 2021 to 2 September 2026.

Both buying and selling appear: 1 purchase worth €6,627, against 1 sale worth €558k. On balance, insiders were net sellers of €552k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: no purchases and 1 sale on the market.

On 7 September 2026 came the latest disclosure, an open-market sale for €558k in SynAct Pharma AB. The latest purchase dates back some time: it was published 291 days ago, on 31 December 2025. The median gap between a trade and its publication by Finansinspektionen is 5 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.